These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 26597117

  • 1. The activation of PI 3-kinase/Akt pathway is involved in the acute effects of simvastatin against ischaemia and reperfusion-induced arrhythmias in anaesthetised dogs.
    Kisvári G, Kovács M, Seprényi G, Végh Á.
    Eur J Pharmacol; 2015 Dec 15; 769():185-94. PubMed ID: 26597117
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
    Végh A, György K, Rastegar MA, Papp JG, Parratt JR.
    Eur J Pharmacol; 1999 Oct 08; 382(2):81-90. PubMed ID: 10528142
    [Abstract] [Full Text] [Related]

  • 4. Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved?
    Kovács M, Kiss A, Gönczi M, Miskolczi G, Seprényi G, Kaszaki J, Kohr MJ, Murphy E, Végh Á.
    PLoS One; 2015 Oct 08; 10(4):e0122243. PubMed ID: 25909651
    [Abstract] [Full Text] [Related]

  • 5. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A, Parratt JR.
    Cardiovasc Res; 2002 Jul 08; 55(1):53-63. PubMed ID: 12062708
    [Abstract] [Full Text] [Related]

  • 6. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjöquist PO, Pernow J.
    Am J Physiol Heart Circ Physiol; 2009 Mar 08; 296(3):H719-27. PubMed ID: 19151258
    [Abstract] [Full Text] [Related]

  • 7. Is there a role of inducible nitric oxide synthase activation in the delayed antiarrhythmic effect of sodium nitrite?
    Demeter-Haludka V, Juhász L, Kovác M, Gardi J, Végh Á.
    Can J Physiol Pharmacol; 2017 Apr 08; 95(4):447-454. PubMed ID: 28177694
    [Abstract] [Full Text] [Related]

  • 8. Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?
    Juhász L, Kiss A, Nyeso E, Kovács M, Seprényi G, Kaszaki J, Végh A.
    Eur J Pharmacol; 2011 Sep 30; 667(1-3):306-13. PubMed ID: 21699894
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
    Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL.
    Circulation; 2002 Mar 26; 105(12):1497-502. PubMed ID: 11914261
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
    Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, Klein HH, Dominiak P, Richardt G.
    J Cardiovasc Pharmacol; 2004 Sep 26; 44(3):348-55. PubMed ID: 15475833
    [Abstract] [Full Text] [Related]

  • 11. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs.
    Végh A, Parratt JR.
    Br J Pharmacol; 2002 Dec 26; 137(7):1107-15. PubMed ID: 12429584
    [Abstract] [Full Text] [Related]

  • 12. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A, Szekeres L, Parratt J.
    Br J Pharmacol; 1992 Nov 26; 107(3):648-52. PubMed ID: 1472963
    [Abstract] [Full Text] [Related]

  • 13. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.
    Cardiovasc Res; 2008 Apr 01; 78(1):116-22. PubMed ID: 18222959
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L, Jiang SS, Xu J, Gong JB, Cheng Y.
    Clin Exp Pharmacol Physiol; 2012 Jan 01; 39(1):20-7. PubMed ID: 22004361
    [Abstract] [Full Text] [Related]

  • 15. Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide.
    Kis A, Végh A, Papp JG, Parratt JR.
    J Mol Cell Cardiol; 1999 Jun 01; 31(6):1229-41. PubMed ID: 10371697
    [Abstract] [Full Text] [Related]

  • 16. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
    Yasuda S, Kobayashi H, Iwasa M, Kawamura I, Sumi S, Narentuoya B, Yamaki T, Ushikoshi H, Nishigaki K, Nagashima K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.
    Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1558-65. PubMed ID: 19286954
    [Abstract] [Full Text] [Related]

  • 17. Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels.
    Kiss A, Juhász L, Huliák I, Végh A.
    Br J Pharmacol; 2008 Dec 01; 155(7):1015-24. PubMed ID: 18846034
    [Abstract] [Full Text] [Related]

  • 18. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine.
    Yamanaka H, Hayashi Y, Iwasaki M, Kamibayashi T, Yamatodani A, Mashimo T.
    Eur J Pharmacol; 2010 Nov 25; 647(1-3):155-60. PubMed ID: 20816810
    [Abstract] [Full Text] [Related]

  • 19. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
    Ning WH, Zhao K.
    Vascul Pharmacol; 2013 Nov 25; 59(3-4):76-82. PubMed ID: 23850990
    [Abstract] [Full Text] [Related]

  • 20. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
    Vegh A, Györgyi K, Papp JG, Sakai K, Parratt JR.
    Eur J Pharmacol; 1996 Jun 03; 305(1-3):163-8. PubMed ID: 8813547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.